Friday, September 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

European Steel Giant Faces Existential Threat from Subsidized Imports

Robert Sasse by Robert Sasse
September 3, 2025
in Commodities, European Markets, Industrial, Turnaround
0
Thyssenkrupp Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Thyssenkrupp, one of Europe’s industrial pillars, is confronting a severe survival challenge as heavily subsidized Chinese steel floods the market. Dennis Grimm, a senior executive at Thyssenkrupp Steel Europe, has issued a stark warning about the potentially devastating impact on the company’s core operations and the broader European steel industry.

Unfair Competition Undermining Market Stability

The European steel sector is grappling with a massive structural imbalance. Chinese competitors, benefiting from significant state subsidies, are exporting steel at prices up to 50% lower than European producers can match. This has created a market environment where approximately 700 million tons of global excess capacity are suppressing prices and threatening the viability of established producers.

For Thyssenkrupp, this translates directly into lost contracts as customers increasingly turn to cheaper alternatives. The company’s steel division, traditionally the operational backbone of the conglomerate, is experiencing substantial order erosion that jeopardizes its fundamental business model.

Grimm emphasized that the consequences extend beyond simple price competition. Critical transformation initiatives are being delayed, blast furnace operations are coming under intense pressure, and the entire industrial value chain is showing signs of fragmentation.

Policy Intervention Becomes Critical

In response to this escalating crisis, Thyssenkrupp’s leadership has outlined specific measures they believe policymakers must implement urgently:

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

  • Immediate trade protections: Swift action against subsidized imports that distort market pricing
  • Comprehensive CBAM implementation: A Carbon Border Adjustment Mechanism without exemptions or loopholes
  • Domestic content requirements: Binding quotas for European-produced materials in public procurement projects

Company management stresses that without rapid deployment of proposed import tariffs and quota reductions, the European steel industry could sustain permanent damage.

Naval Division Suffers Significant Setback

Compounding the steel sector difficulties, Thyssenkrupp’s marine systems subsidiary (TKMS) has encountered a major setback. The division, considered a strategic growth pillar, recently lost a multibillion-euro contract with Norway for new frigate construction to British competition.

The NATO member’s decision to award the contract to a non-German company represents a substantial blow to TKMS, which had been viewed as a promising component of the conglomerate’s diversification strategy.

Despite these mounting challenges, Thyssenkrupp shares have demonstrated remarkable resilience, posting an impressive 188% annual gain. However, analysts caution that without effective political intervention to level the playing field against unfairly subsidized competition, this market performance may prove unsustainable.

Ad

Thyssenkrupp Stock: Buy or Sell?! New Thyssenkrupp Analysis from September 5 delivers the answer:

The latest Thyssenkrupp figures speak for themselves: Urgent action needed for Thyssenkrupp investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 5.

Thyssenkrupp: Buy or sell? Read more here...

Tags: Thyssenkrupp
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

KemPharm Stock
Analysis

Zevra Therapeutics Shares Decline Despite Promising Drug Data

September 5, 2025
American Axle, Manufacturing Stock
Analysis

Institutional Investors Pile Into American Axle & Manufacturing Shares

September 5, 2025
Blade Air Mobility Stock
Healthcare

Strategic Pivot Meets Market Skepticism as Strata Critical Medical Debuts

September 5, 2025
Next Post
Almonty Stock

Almonty Shares Under Pressure Following Steep Quarterly Loss

Rheinmetall Stock

Rheinmetall's Strategic Expansion into Naval and Space Defense Markets

Independent Bank Stock

Independent Bank Capitalizes on Strong Performance with Strategic Investor Outreach

Recommended

Finance_Financialization

Analyst Maintains Buy Rating on Emerald Holding with Revised Price Target

2 years ago
Healthcare Services Stock Exchange

ProSomnus Supporting OSA Patients After Philips Respironics Discontinuation

2 years ago
Pharmaceutical Market Capitalization

Ultragenyx Pharmaceutical Inc Receives PRIME Designation for Groundbreaking Angelman Syndrome Treatment

2 years ago
Encore Wire Stock

Prysmian’s Strategic Acquisition Fuels Record Financial Performance

6 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSFT NFLX NIO Nvidia Opendoor Oracle Pepsi PLTR Realty Income Red Cat Rocket Lab USA Salesforce SMCI Strategy Tesla TGT Tilray TSLA Unitedhealth Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Pile Into American Axle & Manufacturing Shares

Record Quarter for Blue Bird Overshadowed by Insider Selling Activity

Media Spotlight Fuels Investor Interest in Water Resource Firm Cadiz

Lifecore Biomedical Stock: A Study in Contrasting Financial Signals

Ashford Hospitality Trust Generates $33 Million Through Strategic Asset Sales

Strategic Pivot Meets Market Skepticism as Strata Critical Medical Debuts

Trending

Micron Stock
AI & Quantum Computing

Micron’s AI-Driven Surge: High-Bandwidth Memory Fuels Stunning Forecast Upgrade

by Robert Sasse
September 5, 2025
0

A remarkable surge in demand for a specialized, high-performance memory product has propelled Micron Technology into an...

KemPharm Stock

Zevra Therapeutics Shares Decline Despite Promising Drug Data

September 5, 2025
Enanta Stock

Leadership Transition at Enanta Pharmaceuticals Amid Critical Milestones

September 5, 2025
American Axle, Manufacturing Stock

Institutional Investors Pile Into American Axle & Manufacturing Shares

September 5, 2025
Blue Bird Stock

Record Quarter for Blue Bird Overshadowed by Insider Selling Activity

September 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Micron’s AI-Driven Surge: High-Bandwidth Memory Fuels Stunning Forecast Upgrade September 5, 2025
  • Zevra Therapeutics Shares Decline Despite Promising Drug Data September 5, 2025
  • Leadership Transition at Enanta Pharmaceuticals Amid Critical Milestones September 5, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com